Skip to main content
Clinical Trials/CTRI/2018/02/011918
CTRI/2018/02/011918
Not yet recruiting
Phase 3

A Comparative study to Evaluate Efficacy of Shwasa Kuthar Rasa and Pippali Vardhman Rasayan in the management of Chronic Obstructive Pulmonary Disease(Praanavaha Sroto Dushti) - COPD

Ch Brahm Prakash Ayurved Charak Sansthan0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: null- Patients of COPD
Sponsor
Ch Brahm Prakash Ayurved Charak Sansthan
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Ch Brahm Prakash Ayurved Charak Sansthan

Eligibility Criteria

Inclusion Criteria

  • 1\. Age Group between 35\-65 years.
  • 2\. Patients of Both Sexes.
  • 3\. Smoking history current or former active ciggarette smokers or history of occupational exposure to COPD.
  • 4\.Patients present with signs and symptoms of COPD.
  • 5\.Radiographic evidence suggestive of COPD.
  • 6\.Spiro\-metric diagnosis of COPD(as per GOLD criteria)
  • 7\. The patients who are ready to sign informed consent form to participate in study.
  • 8\. The patients who are ready to be consistent in visits during whole trial period.
  • 9\. Firm home address and contact number which is readily accessible during whole course of trial.

Exclusion Criteria

  • 1\)Seriously ill and morbid patients which are unlikely to survive for next 6 months.
  • 2\)Pregnant and lactating women
  • 3\)Patient with alcohol dependence
  • 4\)History of hypersensitivity to any of trial drug
  • 5\)Patient with serious hepatic disorder, renal disorder, diabetes mellitus or any condition that may jeopardize the study
  • 6\)Patient with any other concomitant respiratory disorder
  • 7\)Patient with co\-morbid disorders(Diabetes Mellitus, Pulmonary Tuberculosis ,Rheumatoid Arthritis , Carcinoma)
  • 8\)Patient with poorly controlled hypertension (systolic \>160 mmHg and diastolic \> 100 mmHg)
  • 9\) Patient receiving mast cell stabilizers, anti\-depressants, anticholinergics etc. or any other drugs that may have an influence on the outcome of the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials